Century Therapeutics, Inc. Increase (Decrease) in Security Deposits
Century Therapeutics, Inc. (IPSC) reported Increase (Decrease) in Security Deposits of -$20.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInSecurityDeposits · last filed 2026-08-12
- Century Therapeutics, Inc. increase (decrease) in security deposits for the quarter ending 2026-06-30 was $0.00.
- Century Therapeutics, Inc. increase (decrease) in security deposits for the quarter ending 2026-03-31 was -$20.00K.
- Century Therapeutics, Inc. increase (decrease) in security deposits for the quarter ending 2024-09-30 was $0.00.
- Century Therapeutics, Inc. increase (decrease) in security deposits for the quarter ending 2024-06-30 was $0.00.
| Period end | Increase (Decrease) in Security Deposits 3 month | Increase (Decrease) in Security Deposits 6 month | Increase (Decrease) in Security Deposits 9 month |
|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$20.00K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | -$20.00K 10-Q · filed 2026-05-13 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $20.00K 10-Q · filed 2025-11-13 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $20.00K 10-Q · filed 2025-08-14 | |
| 2024-03-31 | $20.00K 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |